Recombinant Protein Therapeutics CDMO Market Size, Share & Trends Report

Recombinant Protein Therapeutics CDMO Market Size, Share & Trends Analysis Report By Type (Growth Hormones, Interferons, Vaccines, Immunostimulating Agents), By Source, By Indication, By Region, And Segment Forecasts, 2023 - 2030

Report ID: GVR-4-68040-116-2
Number of Pages: 175
Format: Electronic (PDF)

Historical Range: 2018 - 2021
Industry: Healthcare

Market Segmentation

Recombinant Protein Therapeutics CDMO Type Outlook (Revenue, USD Million, 2018 - 2030)
- Growth Hormones
- Interferons
- Vaccines
- Immunostimulating Agents
- Others
Recombinant Protein Therapeutics CDMO Source Outlook (Revenue, USD Million, 2018 - 2030)
- Mammalian Systems
- Microbial Systems
- Others
Recombinant Protein Therapeutics CDMO Indication Outlook (Revenue, USD Million, 2018 - 2030)
- Oncology
- Infectious Diseases
- Immunological Disorders
- Metabolic Disorders
- Haematological Disorders
- Others
Recombinant Protein Therapeutics CDMO Regional Outlook (Revenue, USD Million, 2018 - 2030)
- North America
  - North America Recombinant Protein Therapeutics CDMO Market, By Type Outlook (Revenue, USD Million, 2018 - 2030)
    - Growth Hormones
    - Interferons
    - Vaccines
    - Immunostimulating Agents
    - Others
  - North America Recombinant Protein Therapeutics CDMO Market, By Source Outlook (Revenue, USD Million, 2018 - 2030)
    - Mammalian Systems
    - Microbial Systems
    - Others
  - North America Recombinant Protein Therapeutics CDMO Market, By Indication Outlook (Revenue, USD Million, 2018 - 2030)
    - Oncology
    - Infectious Diseases
    - Immunological Disorders
    - Metabolic Disorders
    - Haematological Disorders
    - Others
  - U.S.
    - U.S. Recombinant Protein Therapeutics CDMO Market, By Type Outlook (Revenue, USD Million, 2018 - 2030)
      - Growth Hormones
      - Interferons
      - Vaccines
      - Immunostimulating Agents
      - Others
    - U.S. Recombinant Protein Therapeutics CDMO Market, By Source Outlook (Revenue, USD Million, 2018 - 2030)
      - Mammalian Systems
      - Microbial Systems
      - Others
    - U.S. Recombinant Protein Therapeutics CDMO Market, By Indication Outlook (Revenue, USD Million, 2018 - 2030)
      - Oncology
      - Infectious Diseases
      - Immunological Disorders
      - Metabolic Disorders
      - Haematological Disorders
      - Others
  - Canada
    - Canada Recombinant Protein Therapeutics CDMO Market, By Type Outlook (Revenue, USD Million, 2018 - 2030)
      - Growth Hormones
      - Interferons
      - Vaccines
      - Immunostimulating Agents
      - Others
    - Canada Recombinant Protein Therapeutics CDMO Market, By Source Outlook (Revenue, USD Million, 2018 - 2030)
      - Mammalian Systems
      - Microbial Systems
      - Others
    - Canada Recombinant Protein Therapeutics CDMO Market, By Indication Outlook (Revenue, USD Million, 2018 - 2030)
      - Oncology
      - Infectious Diseases
      - Immunological Disorders
      - Metabolic Disorders
      - Haematological Disorders
      - Others
- Europe
  - Europe Recombinant Protein Therapeutics CDMO Market, By Type Outlook (Revenue, USD Million, 2018 - 2030)
    - Growth Hormones
    - Interferons
    - Vaccines
    - Immunostimulating Agents
    - Others
  - Europe Recombinant Protein Therapeutics CDMO Market, By Source Outlook (Revenue, USD Million, 2018 - 2030)
    - Mammalian Systems
    - Microbial Systems
    - Others
  - Europe Recombinant Protein Therapeutics CDMO Market, By Indication Outlook (Revenue, USD Million, 2018 - 2030)
    - Oncology
    - Infectious Diseases
    - Immunological Disorders
    - Metabolic Disorders
    - Haematological Disorders
    - Others
  - UK
    - UK Recombinant Protein Therapeutics CDMO Market, By Type Outlook (Revenue, USD Million, 2018 - 2030)
      - Growth Hormones
      - Interferons
      - Vaccines
      - Immunostimulating Agents
      - Others
    - UK Recombinant Protein Therapeutics CDMO Market, By Source Outlook (Revenue, USD Million, 2018 - 2030)
      - Mammalian Systems
      - Microbial Systems
      - Others
    - UK Recombinant Protein Therapeutics CDMO Market, By Indication Outlook (Revenue, USD Million, 2018 - 2030)
      - Oncology
      - Infectious Diseases
      - Immunological Disorders
      - Metabolic Disorders
      - Haematological Disorders
      - Others
  - Germany
    - Germany Recombinant Protein Therapeutics CDMO Market, By Type Outlook (Revenue, USD Million, 2018 - 2030)
      - Growth Hormones
      - Interferons
      - Vaccines
      - Immunostimulating Agents
      - Others
    - Germany Recombinant Protein Therapeutics CDMO Market, By Source Outlook (Revenue, USD Million, 2018 - 2030)
      - Mammalian Systems
      - Microbial Systems
      - Others
    - Germany Recombinant Protein Therapeutics CDMO Market, By Indication Outlook (Revenue, USD Million, 2018 - 2030)
      - Oncology
      - Infectious Diseases
      - Immunological Disorders
      - Metabolic Disorders
      - Haematological Disorders
      - Others
  - France
    - France Recombinant Protein Therapeutics CDMO Market, By Type Outlook (Revenue, USD Million, 2018 - 2030)
      - Growth Hormones
      - Interferons
      - Vaccines
      - Immunostimulating Agents
      - Others
    - France Recombinant Protein Therapeutics CDMO Market, By Source Outlook (Revenue, USD Million, 2018 - 2030)
      - Mammalian Systems
      - Microbial Systems
      - Others
    - France Recombinant Protein Therapeutics CDMO Market, By Indication Outlook (Revenue, USD Million, 2018 - 2030)
      - Oncology
      - Infectious Diseases
      - Immunological Disorders
      - Metabolic Disorders
      - Haematological Disorders
      - Others
  - Italy
    - Italy Recombinant Protein Therapeutics CDMO Market, By Type Outlook (Revenue, USD Million, 2018 - 2030)
      - Growth Hormones
      - Interferons
      - Vaccines
      - Immunostimulating Agents
      - Others
    - Italy Recombinant Protein Therapeutics CDMO Market, By Source Outlook (Revenue, USD Million, 2018 - 2030)
      - Mammalian Systems
      - Microbial Systems
      - Others
    - Italy Recombinant Protein Therapeutics CDMO Market, By Indication Outlook (Revenue, USD Million, 2018 - 2030)
      - Oncology
      - Infectious Diseases
      - Immunological Disorders
      - Metabolic Disorders
      - Haematological Disorders
      - Others
  - Spain
    - Spain Recombinant Protein Therapeutics CDMO Market, By Type Outlook (Revenue, USD Million, 2018 - 2030)
      - Growth Hormones
      - Interferons
      - Vaccines
      - Immunostimulating Agents
      - Others
    - Spain Recombinant Protein Therapeutics CDMO Market, By Source Outlook (Revenue, USD Million, 2018 - 2030)
      - Mammalian Systems
      - Microbial Systems
      - Others
    - Spain Recombinant Protein Therapeutics CDMO Market, By Indication Outlook (Revenue, USD Million, 2018 - 2030)
      - Oncology
      - Infectious Diseases
      - Immunological Disorders
      - Metabolic Disorders
      - Haematological Disorders
      - Others
  - Denmark
    - Denmark Recombinant Protein Therapeutics CDMO Market, By Type Outlook (Revenue, USD Million, 2018 - 2030)
      - Growth Hormones
      - Interferons
      - Vaccines
      - Immunostimulating Agents
      - Others
    - Denmark Recombinant Protein Therapeutics CDMO Market, By Source Outlook (Revenue, USD Million, 2018 - 2030)
      - Mammalian Systems
      - Microbial Systems
      - Others
    - Denmark Recombinant Protein Therapeutics CDMO Market, By Indication Outlook (Revenue, USD Million, 2018 - 2030)
      - Oncology
      - Infectious Diseases
      - Immunological Disorders
      - Metabolic Disorders
      - Haematological Disorders
      - Others
  - Sweden
    - Sweden Recombinant Protein Therapeutics CDMO Market, By Type Outlook (Revenue, USD Million, 2018 - 2030)
      - Growth Hormones
      - Interferons
      - Vaccines
      - Immunostimulating Agents
      - Others
    - Sweden Recombinant Protein Therapeutics CDMO Market, By Source Outlook (Revenue, USD Million, 2018 - 2030)
      - Mammalian Systems
      - Microbial Systems
      - Others
    - Sweden Recombinant Protein Therapeutics CDMO Market, By Indication Outlook (Revenue, USD Million, 2018 - 2030)
      - Oncology
      - Infectious Diseases
      - Immunological Disorders
      - Metabolic Disorders
      - Haematological Disorders
      - Others
  - Norway
    - Norway Recombinant Protein Therapeutics CDMO Market, By Type Outlook (Revenue, USD Million, 2018 - 2030)
      - Growth Hormones
      - Interferons
      - Vaccines
      - Immunostimulating Agents
      - Others
    - Norway Recombinant Protein Therapeutics CDMO Market, By Source Outlook (Revenue, USD Million, 2018 - 2030)
      - Mammalian Systems
      - Microbial Systems
      - Others
    - Norway Recombinant Protein Therapeutics CDMO Market, By Indication Outlook (Revenue, USD Million, 2018 - 2030)
      - Oncology
      - Infectious Diseases
      - Immunological Disorders
      - Metabolic Disorders
      - Haematological Disorders
      - Others
- Asia Pacific
  - Asia Pacific Recombinant Protein Therapeutics CDMO Market, By Type Outlook (Revenue, USD Million, 2018 - 2030)
    - Growth Hormones
    - Interferons
    - Vaccines
    - Immunostimulating Agents
    - Others
  - Asia Pacific Recombinant Protein Therapeutics CDMO Market, By Source Outlook (Revenue, USD Million, 2018 - 2030)
    - Mammalian Systems
    - Microbial Systems
    - Others
  - Asia Pacific Recombinant Protein Therapeutics CDMO Market, By Indication Outlook (Revenue, USD Million, 2018 - 2030)
    - Oncology
    - Infectious Diseases
    - Immunological Disorders
    - Metabolic Disorders
    - Haematological Disorders
    - Others
  - Japan
    - Japan Recombinant Protein Therapeutics CDMO Market, By Type Outlook (Revenue, USD Million, 2018 - 2030)
      - Growth Hormones
      - Interferons
      - Vaccines
      - Immunostimulating Agents
      - Others
    - Japan Recombinant Protein Therapeutics CDMO Market, By Source Outlook (Revenue, USD Million, 2018 - 2030)
      - Mammalian Systems
      - Microbial Systems
      - Others
    - Japan Recombinant Protein Therapeutics CDMO Market, By Indication Outlook (Revenue, USD Million, 2018 - 2030)
      - Oncology
      - Infectious Diseases
      - Immunological Disorders
      - Metabolic Disorders
      - Haematological Disorders
      - Others
  - China
    - China Recombinant Protein Therapeutics CDMO Market, By Type Outlook (Revenue, USD Million, 2018 - 2030)
      - Growth Hormones
      - Interferons
      - Vaccines
      - Immunostimulating Agents
      - Others
    - China Recombinant Protein Therapeutics CDMO Market, By Source Outlook (Revenue, USD Million, 2018 - 2030)
      - Mammalian Systems
      - Microbial Systems
      - Others
    - China Recombinant Protein Therapeutics CDMO Market, By Indication Outlook (Revenue, USD Million, 2018 - 2030)
      - Oncology
      - Infectious Diseases
      - Immunological Disorders
      - Metabolic Disorders
      - Haematological Disorders
      - Others
  - India
    - India Recombinant Protein Therapeutics CDMO Market, By Type Outlook (Revenue, USD Million, 2018 - 2030)
      - Growth Hormones
      - Interferons
      - Vaccines
      - Immunostimulating Agents
      - Others
    - India Recombinant Protein Therapeutics CDMO Market, By Source Outlook (Revenue, USD Million, 2018 - 2030)
      - Mammalian Systems
      - Microbial Systems
      - Others
    - India Recombinant Protein Therapeutics CDMO Market, By Indication Outlook (Revenue, USD Million, 2018 - 2030)
      - Oncology
      - Infectious Diseases
      - Immunological Disorders
      - Metabolic Disorders
      - Haematological Disorders
      - Others
  - Australia
    - Australia Recombinant Protein Therapeutics CDMO Market, By Type Outlook (Revenue, USD Million, 2018 - 2030)
      - Growth Hormones
      - Interferons
      - Vaccines
      - Immunostimulating Agents
      - Others
    - Australia Recombinant Protein Therapeutics CDMO Market, By Source Outlook (Revenue, USD Million, 2018 - 2030)
      - Mammalian Systems
      - Microbial Systems
      - Others
    - Australia Recombinant Protein Therapeutics CDMO Market, By Indication Outlook (Revenue, USD Million, 2018 - 2030)
      - Oncology
      - Infectious Diseases
      - Immunological Disorders
      - Metabolic Disorders
      - Haematological Disorders
      - Others
  - Thailand
    - Thailand Recombinant Protein Therapeutics CDMO Market, By Type Outlook (Revenue, USD Million, 2018 - 2030)
      - Growth Hormones
      - Interferons
      - Vaccines
      - Immunostimulating Agents
      - Others
    - Thailand Recombinant Protein Therapeutics CDMO Market, By Source Outlook (Revenue, USD Million, 2018 - 2030)
      - Mammalian Systems
      - Microbial Systems
      - Others
    - Thailand Recombinant Protein Therapeutics CDMO Market, By Indication Outlook (Revenue, USD Million, 2018 - 2030)
      - Oncology
      - Infectious Diseases
      - Immunological Disorders
      - Metabolic Disorders
      - Haematological Disorders
      - Others
  - South Korea
    - South Korea Recombinant Protein Therapeutics CDMO Market, By Type Outlook (Revenue, USD Million, 2018 - 2030)
      - Growth Hormones
      - Interferons
      - Vaccines
      - Immunostimulating Agents
      - Others
    - South Korea Recombinant Protein Therapeutics CDMO Market, By Source Outlook (Revenue, USD Million, 2018 - 2030)
      - Mammalian Systems
      - Microbial Systems
      - Others
    - South Korea Recombinant Protein Therapeutics CDMO Market, By Indication Outlook (Revenue, USD Million, 2018 - 2030)
      - Oncology
      - Infectious Diseases
      - Immunological Disorders
      - Metabolic Disorders
      - Haematological Disorders
      - Others
- Latin America
  - Latin America Recombinant Protein Therapeutics CDMO Market, By Type Outlook (Revenue, USD Million, 2018 - 2030)
    - Growth Hormones
    - Interferons
    - Vaccines
    - Immunostimulating Agents
    - Others
  - Latin America Recombinant Protein Therapeutics CDMO Market, By Source Outlook (Revenue, USD Million, 2018 - 2030)
    - Mammalian Systems
    - Microbial Systems
    - Others
  - Latin America Recombinant Protein Therapeutics CDMO Market, By Indication Outlook (Revenue, USD Million, 2018 - 2030)
    - Oncology
    - Infectious Diseases
    - Immunological Disorders
    - Metabolic Disorders
    - Haematological Disorders
    - Others
  - Brazil
    - Brazil Recombinant Protein Therapeutics CDMO Market, By Type Outlook (Revenue, USD Million, 2018 - 2030)
      - Growth Hormones
      - Interferons
      - Vaccines
      - Immunostimulating Agents
      - Others
    - Brazil Recombinant Protein Therapeutics CDMO Market, By Source Outlook (Revenue, USD Million, 2018 - 2030)
      - Mammalian Systems
      - Microbial Systems
      - Others
    - Brazil Recombinant Protein Therapeutics CDMO Market, By Indication Outlook (Revenue, USD Million, 2018 - 2030)
      - Oncology
      - Infectious Diseases
      - Immunological Disorders
      - Metabolic Disorders
      - Haematological Disorders
      - Others
  - Mexico
    - Mexico Recombinant Protein Therapeutics CDMO Market, By Type Outlook (Revenue, USD Million, 2018 - 2030)
      - Growth Hormones
      - Interferons
      - Vaccines
      - Immunostimulating Agents
      - Others
    - Mexico Recombinant Protein Therapeutics CDMO Market, By Source Outlook (Revenue, USD Million, 2018 - 2030)
      - Mammalian Systems
      - Microbial Systems
      - Others
    - Mexico Recombinant Protein Therapeutics CDMO Market, By Indication Outlook (Revenue, USD Million, 2018 - 2030)
      - Oncology
      - Infectious Diseases
      - Immunological Disorders
      - Metabolic Disorders
      - Haematological Disorders
      - Others
  - Argentina
    - Argentina Recombinant Protein Therapeutics CDMO Market, By Type Outlook (Revenue, USD Million, 2018 - 2030)
      - Growth Hormones
      - Interferons
      - Vaccines
      - Immunostimulating Agents
      - Others
    - Argentina Recombinant Protein Therapeutics CDMO Market, By Source Outlook (Revenue, USD Million, 2018 - 2030)
      - Mammalian Systems
      - Microbial Systems
      - Others
    - Argentina Recombinant Protein Therapeutics CDMO Market, By Indication Outlook (Revenue, USD Million, 2018 - 2030)
      - Oncology
      - Infectious Diseases
      - Immunological Disorders
      - Metabolic Disorders
      - Haematological Disorders
      - Others
- Middle East & Africa
  - Middle East & Africa Recombinant Protein Therapeutics CDMO Market, By Type Outlook (Revenue, USD Million, 2018 - 2030)
    - Growth Hormones
    - Interferons
    - Vaccines
    - Immunostimulating Agents
    - Others
  - Middle East & Africa Recombinant Protein Therapeutics CDMO Market, By Source Outlook (Revenue, USD Million, 2018 - 2030)
    - Mammalian Systems
    - Microbial Systems
    - Others
  - Middle East & Africa Recombinant Protein Therapeutics CDMO Market, By Indication Outlook (Revenue, USD Million, 2018 - 2030)
    - Oncology
    - Infectious Diseases
    - Immunological Disorders
    - Metabolic Disorders
    - Haematological Disorders
    - Others
  - South Africa
    - South Africa Recombinant Protein Therapeutics CDMO Market, By Type Outlook (Revenue, USD Million, 2018 - 2030)
      - Growth Hormones
      - Interferons
      - Vaccines
      - Immunostimulating Agents
      - Others
    - South Africa Recombinant Protein Therapeutics CDMO Market, By Source Outlook (Revenue, USD Million, 2018 - 2030)
      - Mammalian Systems
      - Microbial Systems
      - Others
    - South Africa Recombinant Protein Therapeutics CDMO Market, By Indication Outlook (Revenue, USD Million, 2018 - 2030)
      - Oncology
      - Infectious Diseases
      - Immunological Disorders
      - Metabolic Disorders
      - Haematological Disorders
      - Others
  - Saudi Arabia
    - Saudi Arabia Recombinant Protein Therapeutics CDMO Market, By Type Outlook (Revenue, USD Million, 2018 - 2030)
      - Growth Hormones
      - Interferons
      - Vaccines
      - Immunostimulating Agents
      - Others
    - Saudi Arabia Recombinant Protein Therapeutics CDMO Market, By Source Outlook (Revenue, USD Million, 2018 - 2030)
      - Mammalian Systems
      - Microbial Systems
      - Others
    - Saudi Arabia Recombinant Protein Therapeutics CDMO Market, By Indication Outlook (Revenue, USD Million, 2018 - 2030)
      - Oncology
      - Infectious Diseases
      - Immunological Disorders
      - Metabolic Disorders
      - Haematological Disorders
      - Others
  - UAE
    - UAE Recombinant Protein Therapeutics CDMO Market, By Type Outlook (Revenue, USD Million, 2018 - 2030)
      - Growth Hormones
      - Interferons
      - Vaccines
      - Immunostimulating Agents
      - Others
    - UAE Recombinant Protein Therapeutics CDMO Market, By Source Outlook (Revenue, USD Million, 2018 - 2030)
      - Mammalian Systems
      - Microbial Systems
      - Others
    - UAE Recombinant Protein Therapeutics CDMO Market, By Indication Outlook (Revenue, USD Million, 2018 - 2030)
      - Oncology
      - Infectious Diseases
      - Immunological Disorders
      - Metabolic Disorders
      - Haematological Disorders
      - Others
  - Kuwait
    - Kuwait Recombinant Protein Therapeutics CDMO Market, By Type Outlook (Revenue, USD Million, 2018 - 2030)
      - Growth Hormones
      - Interferons
      - Vaccines
      - Immunostimulating Agents
      - Others
    - Kuwait Recombinant Protein Therapeutics CDMO Market, By Source Outlook (Revenue, USD Million, 2018 - 2030)
      - Mammalian Systems
      - Microbial Systems
      - Others
    - Kuwait Recombinant Protein Therapeutics CDMO Market, By Indication Outlook (Revenue, USD Million, 2018 - 2030)
      - Oncology
      - Infectious Diseases
      - Immunological Disorders
      - Metabolic Disorders
      - Haematological Disorders
      - Others

Report content

Qualitative Analysis

Industry overview
Industry trends
Market drivers and restraints
Market size
Growth prospects
Porter’s analysis
PESTEL analysis
Key market opportunities prioritized
Competitive landscape
- Company overview
- Financial performance
- Product benchmarking
- Latest strategic developments

Quantitative Analysis

Market size, estimates, and forecast from 2018 to 2030
Market estimates and forecast for product segments up to 2030
Regional market size and forecast for product segments up to 2030
Market estimates and forecast for application segments up to 2030
Regional market size and forecast for application segments up to 2030
Company financial performance

GET A FREE SAMPLE

This FREE sample includes market data points, ranging from trend analyses to market estimates & forecasts. See for yourself.

Or view our licence options:

NEED A CUSTOM REPORT?

We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports, as well as offer affordable discounts for start-ups & universities.

ESOMAR certified & member

ISO Certified

We are GDPR and CCPA compliant! Your transaction & personal information is safe and secure. For more details, please read our privacy policy.